President Donald Trump announced a 100% tariff on foreign brand-name drugs starting October 1, 2025, raising concerns about potential price increases for essential medications, particularly those manufactured overseas. Experts are uncertain about which drugs will be affected, how many companies will qualify for exemptions, and whether these costs will ultimately be passed on to patients or absorbed by insurers.
